We'll continue to monitor emerging NAC research and update our recommendations as new evidence becomes available
Overall, a molecularly targeted approach to micronutrients represents an emerging precision-nutrition strategy aimed at improving metabolic, reproductive, and inflammatory outcomes in women with PCOS
has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organized by Angellini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Elysium, Heptares, Global Medical Education, Invicro, Janssen, Karuna, Lundbeck, Merck, Neurocrine, Ontrack/Pangea, Otsuka, Sunovion, Recordati, Roche, Rovi, and Viatris/Mylan
10 mg Vitamin B6 (as Pyridoxine HCl)
Management of Type 2 Diabetes: Selecting Amongst Available Pharmacological Agents